Dx which matrix
(Die Seite wurde neu angelegt: „{{tp|p=32304208|t=ä. Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources |pdf=|usr=}} {{tp|p=32313785|t=ä. A Review of Salivary Diagnosti…“)
Aktuelle Version vom 26. Juni 2020, 10:21 Uhr
32304208 ä. Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources
32313785 ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19
32290684 2020. Exhaled breath condensate as a potential specimen for diagnosing COVID-19
32273299 2020. Self-screening to reduce medical resource consumption facing the COVID-19 pandemic
32047895 ä. Consistent Detection of 2019 Novel Coronavirus in Saliva
32271374 ä. Effect of throat washings on detection of 2019 novel coronavirus
32300101 2020. Saliva: potential diagnostic value and transmission of 2019-nCoV
32241023 ä. Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan
32342674 2020. Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening
32377507 ä. A Cautionary Tale of False-Negative Nasopharyngeal COVID-19 Testing
32246822 ä. Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads
32295896 2020. Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage
32102856 2020. Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19
32317257 2020. Saliva as a non-invasive specimen for detection of SARS-CoV-2
32317256 2020. Validation of the Hologic s Aptima Unisex and Multitest Specimen collection kits used for Endocervical and Male Urethral Swab Specimen (Aptima Swab) for sample collection of SARS-CoV-2
32341141 2020. Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR
32315809 ä. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously
32114193 2020. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests
32224986 2020. Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV)
32328218 ä. Salivary diagnostics in COVID-19: Future research implications
32403007 2020. Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic
32311181 2020. SARS-CoV-2: What can saliva tell us?
32295895 2020. Comparison of Copan ESwab and FLOQSwab for COVID-19 Diagnosis: Working around a Supply Shortage
32380382 ä. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays
| 32357377 2020. Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus (SARS-CoV-2) safely: How to dress, undress, and technical notes |
| 32352180 2020. COVID-19: Nasal and oropharyngeal swab |
32329138 2020. Who should perform the rhinopharyngeal swab in COVID-19 positive patients?
32171389 2020. SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients
32179122 2020. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?
| 32297981 2020. COVID-19: Recommended sampling sites at different stage of the disease |
32380210 ä. The Impacts of Viral Inactivating Methods On Quantitative RT-PCR for COVID-19
32367861 2020. Bronchoalveolar specimen can help detect COVID-19 in suspicious case with negative PCR for nasopharyngeal specimen test
| 32357381 2020. Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview |
C7200353 2020. A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection
C7187661 ä. Group Testing for SARS-CoV-2: Forward to the Past?
32301745 2020. Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19)
32400235 2020. The role of lower respiratory tract samples in the diagnosis of COVID-19.
32429101 2020. Use of Saliva for Diagnosis and Monitoring the SARS-CoV-2: A General Perspective.
32456750 2020. Hospital infection and COVID-19: Do not put all your eggs on the "swab" tests.
32492294 2020. Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing.
32393482 2020. Open Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck.
32380210 2020. The impacts of viral inactivating methods on quantitative RT-PCR for COVID-19
32330305 2020. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens
32459137 2020. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.
32342928 2020. Upper respiratory tract sampling in COVID-19
32159775 2020. Detection of SARS-CoV-2 in Different Types of Clinical Specimens
32250394 2020. Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2
32506693 2020. Diagnosis of COVID-19 infection in children: less nasopharyngeal swabs, more saliva.
32501019 2020. 'Self-collected upper respiratory tract swabs for COVID-19 test': A feasible way to increase overall testing rate and conserve resources in South Africa.
32427340 2020. Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs.
| 32450754 2020. Inappropriate Nasopharyngeal Sampling for SARS-CoV-2 Detection Is a Relevant Cause of False-Negative Reports. |
32407189 2020. Recommendation of fecal specimen for routine molecular detection of SARS-CoV-2 and for COVID-19 discharge criteria.
32294815 2020. [Clinical observation on increasing the positive rate of novel coronavirus nucleic acid tests by sputum excretion induced by nebulizer therapy].
32229604 2020. Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing.
32385433 2020. Saliva testing for COVID-19?
32472673 2020. Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.
32397487 2020. Saliva-Friend and Foe in the COVID-19 Outbreak.
| 32302471 2020. How to Obtain a Nasopharyngeal Swab Specimen. |
32463086 2020. Clinical Utility of Buccal Swabs for Sars-Cov-2 Detection in Covid-19-Infected Children.
32487335 2020. Nasopharyngeal swab collection in the suspicion of Covid-19.
32467359 2020. Influence of Different Inactivation Methods on Severe Acute Respiratory Syndrome Coronavirus 2 RNA Copy Number.
| 32502333 2020. Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens. |
32414839 2020. Stability of SARS-CoV-2 in PBS for Molecular Detection.
32414838 2020. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
32404481 2020. Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic.
32419639 2020. Viral loads in throat and anal swabs in children infected with SARS-CoV-2.
32492721 2020. COVID-19 Pandemic and Role of Human Saliva as a Testing Biofluid in Point-of-Care Technology.
32172228 2020. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
C7194818 ä. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people
32388468 2020. Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening
32380382 2020. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays
32298676 ä. Saliva is a reliable tool to detect SARS-CoV-2
32422408 2020. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study.
32534909 2020. First detection of SARS-CoV-2 by real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in pleural fluid.
32386354 2020. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?
32369202 2020. Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR.
32504740 2020. Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.
32405257 2020. Validation of SARS-CoV-2 detection across multiple specimen types.
32389155 2020. Utility of retesting for diagnosis of SARS-CoV-2/COVID-19 in hospitalized patients: Impact of the interval between tests.
32389132 2020. Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic use and save personal protective equipment and swabs.
32381379 2020. Saliva samples as an alternative for novel coronavirus (COVID-19) diagnosis.
32532934 2020. COVID 19 diagnostic multiplicity and its role in community surveillance and control.
32425660 2020. A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2.
32344452 2020. Rapid detection of SARS-CoV-2 in saliva: can an endodontist take the lead in point-of-care COVID-19 testing?
32383097 2020. Nasopharyngeal swabs during SARS-CoV-2 pandemic: a role for the otolaryngologist.
32401343 2020. Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.
32219885 2020. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.
32330297 2020. Optimization of group size in pool testing strategy for SARS-CoV-2: A simple mathematical model.
32166939 2020. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]
32405270 2020. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium.
32533461 2020. Positive tracheal SARS-CoV-2 RNA test after three negative SARS-CoV-2 RNA tests in a patient with COVID-19.
